Platforms - Luminex Solutions
Built around three core technologies – the fluorescently dyed microspheres, or beads, provided from Luminex; a flow cytometer with two lasers and associated optics; and a high-speed digital processor able to efficiently manage digital output – the Luminex platform employs fluorescent methods for detection, using the bead sets to identify the analytes, and detection antibodies to measure the quantity of analyte.
KCAS knows how to put the luminex to work for you
Our experience with a variety of matrices, including plasma, serum, CSF, soft tissues, hard tissues, sputum, and vitreous and aqueous humor enable us to support a wide range of therapeutic areas both non-clinical and clinical. Clients come to KCAS because we help strategize which biomarkers to multiplex, the best platform to use, and the level of regulation required.
KCAS Luminex Services
Should define what it is first… ie Bridging Validation is a run when one is trying to move fro…
Methods transferred into a new laboratory need to be re-established for regulatory compliance….
Critical reagents are essential components of analytical methods whose unique characteristics…
At KCAS, methods are developed with a fit-for-purpose design in mind, based on our Client’s ne…
A fit-for-purpose approach is used by KCAS in method qualifications. Each method is designed t…
KCAS has extensive experience in validating methods in a wide range of bioanalytical platforms…
Multi-plex analysis of biomarkers is a powerful tool for screening of many analytes in a small…
Regulated clinical bioanalysis is a key focus at KCAS, supporting both human and animal health…
Non-clinical (or often referred to as preclinical studies) non GLP samples are often used for…
The discovery phase in drug development requires rapid and reliable data in making key decisio…
PD Analysis is the assistance with design, regulatory requirements and final data interpretati…
Tissue bioanalysis is an essential area in understanding the extent of drug distribution, meta…